JP2009542788A - クリンダマイシンの塩酸塩を有する薬剤デリバリーポリマー - Google Patents

クリンダマイシンの塩酸塩を有する薬剤デリバリーポリマー Download PDF

Info

Publication number
JP2009542788A
JP2009542788A JP2009518960A JP2009518960A JP2009542788A JP 2009542788 A JP2009542788 A JP 2009542788A JP 2009518960 A JP2009518960 A JP 2009518960A JP 2009518960 A JP2009518960 A JP 2009518960A JP 2009542788 A JP2009542788 A JP 2009542788A
Authority
JP
Japan
Prior art keywords
insert
hydrogel matrix
vagina
clindamycin
clindamycin hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009518960A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009542788A5 (enExample
Inventor
アン ハリデー，ジャネット
アンドリュー カール，デニス
ボイド，リン
マクレガー，モニカ
トム，アンドリー
ケリー，リンダ
アレクサンダー リビングストーン，マーク
モートン カリー，リリアス
Original Assignee
コントロールド・セラピューティクス（スコットランド）・リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by コントロールド・セラピューティクス（スコットランド）・リミテッド filed Critical コントロールド・セラピューティクス（スコットランド）・リミテッド
Publication of JP2009542788A publication Critical patent/JP2009542788A/ja
Publication of JP2009542788A5 publication Critical patent/JP2009542788A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2009518960A 2006-07-12 2007-07-12 クリンダマイシンの塩酸塩を有する薬剤デリバリーポリマー Pending JP2009542788A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80714906P 2006-07-12 2006-07-12
PCT/GB2007/002604 WO2008007098A2 (en) 2006-07-12 2007-07-12 Drug delivery polymer with hydrochloride salt of clindamycin

Publications (2)

Publication Number Publication Date
JP2009542788A true JP2009542788A (ja) 2009-12-03
JP2009542788A5 JP2009542788A5 (enExample) 2010-09-02

Family

ID=38686816

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009518960A Pending JP2009542788A (ja) 2006-07-12 2007-07-12 クリンダマイシンの塩酸塩を有する薬剤デリバリーポリマー

Country Status (10)

Country Link
US (1) US20080160065A1 (enExample)
EP (1) EP2037938A2 (enExample)
JP (1) JP2009542788A (enExample)
CN (1) CN101500583B (enExample)
AU (1) AU2007274081B2 (enExample)
BR (1) BRPI0713203A2 (enExample)
CA (1) CA2657533A1 (enExample)
MX (1) MX2009000053A (enExample)
RU (1) RU2444364C2 (enExample)
WO (1) WO2008007098A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
EP2244782A4 (en) 2008-01-25 2011-09-14 Univ Utah Res Found POLYMER WITH LINEAR ORDER RELEASE
CN102335113A (zh) * 2010-07-20 2012-02-01 杭州赛利药物研究所有限公司 克林霉素磷酸酯阴道缓释凝胶及其制备方法
US9198957B2 (en) * 2011-01-31 2015-12-01 The Trustees Of Columbia University In The City Of New York Treatment and prevention of bacterial vaginosis and Gardnerella vaginalis infections
EP3648779A4 (en) * 2017-07-07 2021-03-17 Osel, Inc. USING VAGINAL LACTOBACILLI TO IMPROVE THE SUCCESS RATE OF IN VITRO FERTILIZATION

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56500253A (enExample) * 1979-03-21 1981-03-05
JPH0670952A (ja) * 1992-07-16 1994-03-15 Controlled Therapeutics Scotland Ltd 回収可能なペッサリー
JP2000502691A (ja) * 1995-12-27 2000-03-07 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 生物接着性固形剤形
JP2001513550A (ja) * 1997-08-27 2001-09-04 ヘクサル・アクチェンゲゼルシャフト 新規医薬組成物
JP2002515069A (ja) * 1997-06-11 2002-05-21 ユーエムディー，インコーポレイテッド 月経困難症の治療のための装置および方法
WO2004029125A1 (en) * 2002-09-27 2004-04-08 Controlled Therapeutics (Scotland) Limited Water-swellable polymers
WO2006013335A1 (en) * 2004-08-05 2006-02-09 Controlled Therapeutics (Scotland) Ltd. Stabilised prostaglandin composition

Family Cites Families (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3565991A (en) * 1968-04-22 1971-02-23 Searle & Co Methods for use and compositions of 17alpha-ethyl-19-nortestosterone and carriers for the sustained release of steroids
US3830907A (en) * 1968-04-22 1974-08-20 Searle & Co Compositions for the sustained release of 17alpha-ethyl-19-nortestosterone
US3860701A (en) * 1968-04-22 1975-01-14 Searle & Co Method for use and compositions of 11-lower alkyl steroids and drug delivery system for the controlled elution of 11-lower alkyl steroids
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3896819A (en) * 1969-04-01 1975-07-29 Alejandro Zaffaroni IUD having a replenishing drug reservoir
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3734097A (en) * 1969-04-01 1973-05-22 Alza Corp Therapeutic adhesive tape
US3967618A (en) * 1969-04-01 1976-07-06 Alza Corporation Drug delivery device
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3948262A (en) * 1969-04-01 1976-04-06 Alza Corporation Novel drug delivery device
US3760805A (en) * 1971-01-13 1973-09-25 Alza Corp Osmotic dispenser with collapsible supply container
US4034756A (en) * 1971-01-13 1977-07-12 Alza Corporation Osmotically driven fluid dispenser
US3941880A (en) * 1971-02-22 1976-03-02 G. D. Searle & Co. Method for use of 11-lower alkyl steroids
US3731683A (en) * 1971-06-04 1973-05-08 Alza Corp Bandage for the controlled metering of topical drugs to the skin
US3892842A (en) * 1971-09-01 1975-07-01 Alza Corp Intrauterine contraceptive device for releasing steroid having double bond functionality
US3948254A (en) * 1971-11-08 1976-04-06 Alza Corporation Novel drug delivery device
US3867933A (en) * 1973-03-06 1975-02-25 Tecna Corp Intrauterine device and process of making the same
US4036227A (en) * 1973-04-25 1977-07-19 Alza Corporation Osmotic releasing device having a plurality of release rate patterns
FR2250520B1 (enExample) * 1973-11-09 1977-04-15 Cournut Rene
US4142526A (en) * 1974-12-23 1979-03-06 Alza Corporation Osmotic releasing system with means for changing release therefrom
US4215691A (en) * 1978-10-11 1980-08-05 Alza Corporation Vaginal contraceptive system made from block copolymer
US4286587A (en) * 1978-10-11 1981-09-01 Alza Corporation Vaginal drug delivery system made from polymer
US5017382A (en) * 1979-03-21 1991-05-21 National Research Development Corporation Controlled release compositions (II)
US4250611A (en) * 1979-04-19 1981-02-17 Alza Corporation Process for making drug delivery device with reservoir
US4402695A (en) * 1980-01-21 1983-09-06 Alza Corporation Device for delivering agent in vagina
DE3017989C2 (de) * 1980-05-10 1982-05-19 IPOS Gesellschaft für integrierte Prothesen-Entwicklung und orthopädietechnischen Service mbH & Co KG, 2120 Lüneburg "Auffangbeutel für künstliche Darmausgänge"
US4694238A (en) * 1984-01-10 1987-09-15 Peter Norton Dual voltage power supply system for vehicles
US4596576A (en) * 1984-10-12 1986-06-24 Akzo N.V. Release system for two or more active substances
US5731303A (en) * 1985-12-04 1998-03-24 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery compositions
US5023252A (en) * 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
JP2538953B2 (ja) * 1987-11-17 1996-10-02 三菱重工業株式会社 工業用ロボットのバランス機構
US5002540A (en) * 1989-05-22 1991-03-26 Warren Kirschbaum Intravaginal device and method for delivering a medicament
US5176907A (en) * 1991-08-13 1993-01-05 The Johns Hopkins University School Of Medicine Biocompatible and biodegradable poly (phosphoester-urethanes)
DE69332954D1 (de) * 1992-10-21 2003-06-12 Gynetech Lab Inc Abgabesystem bestehend aus einem vaginaschwamm
US5514698A (en) * 1994-03-21 1996-05-07 Ortho Pharmaceutical Corporation Antifungal vaginal cream composition
IL116433A (en) * 1994-12-19 2002-02-10 Galen Chemicals Ltd INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORS
US6413536B1 (en) * 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US5747058A (en) * 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
US7833543B2 (en) * 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
US5968542A (en) * 1995-06-07 1999-10-19 Southern Biosystems, Inc. High viscosity liquid controlled delivery system as a device
US6201065B1 (en) * 1995-07-28 2001-03-13 Focal, Inc. Multiblock biodegradable hydrogels for drug delivery and tissue treatment
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
US6572874B1 (en) * 1998-05-15 2003-06-03 Umd, Inc. Vaginal delivery of bisphosphonates
US6039968A (en) * 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
EP1007581A1 (en) * 1997-08-25 2000-06-14 Union Carbide Chemicals & Plastics Technology Corporation Biodegradable lactone copolymers
EP1051437B1 (en) * 1998-01-28 2005-08-17 Bristol-Myers Squibb Company Methods of preparing polyurethane adhesives and adhesives produced thereby
US6028057A (en) * 1998-02-19 2000-02-22 Thorn Bioscience, Llc Regulation of estrus and ovulation in gilts
US6013637A (en) * 1998-06-12 2000-01-11 Dermik Laboratories Inc. Anti-acne method and composition
GB9826192D0 (en) * 1998-12-01 1999-01-20 Controlled Theraputics Scotlan Oral transmucosal delivery
IT1317735B1 (it) * 2000-01-26 2003-07-15 Nicox Sa Sali di agenti antimicrobici.
US6740333B2 (en) * 2000-07-07 2004-05-25 Anestic Aps Suppository and composition comprising at least one polyethylene glycol
US6811549B2 (en) * 2001-02-16 2004-11-02 William H. Fleming Administration of therapeutic or diagnostic agents using interlabial pad
AU2003207961A1 (en) * 2002-01-16 2003-07-30 Ramot At Tel Aviv University Ltd. Compositions and their use for enhancing and inhibiting fertilization
AU2003208679A1 (en) * 2002-02-08 2003-09-02 Advanced Animal Technology Limited Control of a biological function
US6861503B2 (en) * 2002-02-27 2005-03-01 Poly-Med, Inc. Interlinked solid polyethylene glycols and copolymers thereof
US7179481B2 (en) * 2002-09-19 2007-02-20 Kimberly-Clark Worldwide, Inc. Vaginal health products
GB0301577D0 (en) * 2003-01-23 2003-02-26 Edko Pazarlama Tanitim Ltd Sti Topical pharmaceutical and/or cosmetic dispense systems
WO2004091579A1 (en) * 2003-04-16 2004-10-28 Pharmacia Corporation Stabilized prostaglandin formulation
ATE461681T1 (de) * 2003-04-29 2010-04-15 Gen Hospital Corp Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
US8399013B2 (en) * 2003-06-26 2013-03-19 Poly-Med, Inc. Partially absorbable fiber-reinforced composites for controlled drug delivery
JP2007505927A (ja) * 2003-09-19 2007-03-15 ドラッグテック コーポレイション 薬物送達システム
DE50300325D1 (de) * 2003-11-03 2005-03-31 Peter-Hansen Volkmann Vaginalpflegezusammensetzung
EP1555278A1 (en) * 2004-01-15 2005-07-20 Innocore Technologies B.V. Biodegradable multi-block co-polymers
CN100449137C (zh) * 2004-01-28 2009-01-07 新冷凝器公司 从曲轴箱废气清除污染物的设备
US20070166382A1 (en) * 2004-03-26 2007-07-19 Kiser Patrick F Bioresponsive polymer system for delivery of microbicides
US7485666B2 (en) * 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
KR101229701B1 (ko) * 2004-07-09 2013-02-05 라보라토이레 에이치알에이 파르마 프로게스테론 수용체 조절제를 함유하는 서방형 조성물
US20060078616A1 (en) * 2004-08-30 2006-04-13 Georgewill Dawaye A Thermoreversible pharmaceutical formulation for anti-microbial agents comprising poloxamer polymers and hydroxy fatty acid ester of polyethylene glycol
US20060093675A1 (en) * 2004-10-29 2006-05-04 Mathew Ebmeier Intravaginal treatment of vaginal infections with metronidazole compositions
WO2006084082A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
TW200744610A (en) * 2005-06-21 2007-12-16 Organon Nv New regimens for controlled drug delivery devices for contraception
TW200727920A (en) * 2005-06-21 2007-08-01 Organon Nv New regimens for oral monophasic contraceptives
AU2006321915B2 (en) * 2005-12-06 2012-04-26 Covidien Lp Bioabsorbable surgical composition
EP1960447A4 (en) * 2005-12-08 2010-12-01 Tyco Healthcare BIOCOMPATIBLE SURGICAL COMPOSITIONS
US20070148105A1 (en) * 2005-12-22 2007-06-28 Donald Spector Compositions and methods comprising magnetic particles for health use
US8047980B2 (en) * 2006-07-10 2011-11-01 Mcneil-Ppc, Inc. Method of treating urinary incontinence
WO2008062009A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Delivery system for risperidone
SG195525A1 (en) * 2007-06-26 2013-12-30 Warner Chilcott Co Llc Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs
US20110059040A1 (en) * 2007-06-27 2011-03-10 Kiser Patrick F Compositions and methods for inhibiting viral and bacterial activity
US8741329B2 (en) * 2007-09-21 2014-06-03 Merck Sharp & Dohme B.V. Drug delivery system
EP2244782A4 (en) * 2008-01-25 2011-09-14 Univ Utah Res Found POLYMER WITH LINEAR ORDER RELEASE
FI20085277A0 (fi) * 2008-04-02 2008-04-02 Bayer Schering Pharma Oy Kohdunsisäinen järjestelmä
US20110150955A1 (en) * 2009-12-23 2011-06-23 Shannon Elizabeth Klingman Products and Methods for Reducing Malodor from the Pudendum

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56500253A (enExample) * 1979-03-21 1981-03-05
JPH0670952A (ja) * 1992-07-16 1994-03-15 Controlled Therapeutics Scotland Ltd 回収可能なペッサリー
JP2000502691A (ja) * 1995-12-27 2000-03-07 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 生物接着性固形剤形
JP2002515069A (ja) * 1997-06-11 2002-05-21 ユーエムディー，インコーポレイテッド 月経困難症の治療のための装置および方法
JP2001513550A (ja) * 1997-08-27 2001-09-04 ヘクサル・アクチェンゲゼルシャフト 新規医薬組成物
WO2004029125A1 (en) * 2002-09-27 2004-04-08 Controlled Therapeutics (Scotland) Limited Water-swellable polymers
WO2006013335A1 (en) * 2004-08-05 2006-02-09 Controlled Therapeutics (Scotland) Ltd. Stabilised prostaglandin composition

Also Published As

Publication number Publication date
HK1137646A1 (en) 2010-08-06
WO2008007098A3 (en) 2008-03-27
CN101500583B (zh) 2012-05-23
AU2007274081B2 (en) 2012-08-02
RU2009104695A (ru) 2010-08-20
EP2037938A2 (en) 2009-03-25
RU2444364C2 (ru) 2012-03-10
CN101500583A (zh) 2009-08-05
WO2008007098A2 (en) 2008-01-17
CA2657533A1 (en) 2008-01-17
BRPI0713203A2 (pt) 2012-04-03
US20080160065A1 (en) 2008-07-03
MX2009000053A (es) 2009-02-23
AU2007274081A1 (en) 2008-01-17

Similar Documents

Publication Publication Date Title
JP2009542788A (ja) クリンダマイシンの塩酸塩を有する薬剤デリバリーポリマー
RU2032402C1 (ru) Композиция для лечения вагинита и способ его лечения
DE60020351T2 (de) Azalid-antibiotika zur topischen behandlung oder vorbeugung okulärer infektionen
US20060018951A1 (en) pH-responsive film for intravaginal delivery of a beneficial agent
KR20070057698A (ko) 이성 감염의 국소 치료 또는 예방을 위한 국소 이성 조성물및 방법
US11129896B2 (en) Topical formulations and treatments
US6913759B2 (en) Gel composition and method for treatment of vaginal infections
US20050095245A1 (en) Pharmaceutical delivery system
US10039709B2 (en) Bioadhesive compositions for epithelial drug delivery
WO2012147056A1 (en) Vaginal composition based on alkyl polyglucosides
JPH08231405A (ja) 局所的眼科用途の為のトブラマイシンとステロイドの組合わせ
RU2401102C2 (ru) Фармацевтическая композиция для лечения урогенитальных инфекций
CA2635994A1 (en) Drug delivery system for bioadhesion to a vulvovaginal surface
HK1137646B (en) Drug delivery polymer with hydrochloride salt of clindamycin
US20240315959A1 (en) Method and device for providing effective contraception
WO2024155775A2 (en) Compositions and techniques for treatment of polycystic ovarian syndrome (pcos) and endometriosis
WO2024155777A2 (en) Compositions and techniques for treatment of polycystic ovarian syndrome (pcos) and endometriosis
RU2498806C2 (ru) Фармацевтический состав для лечения инфекционных воспалительных заболеваний в гинекологии и способ его получения
TW201121581A (en) Pharmaceutical dosage form for treating, managing or preventing vaginal infections or cervical cancer and gel composition and hydrophilic foam comprised therein
JP2020509086A (ja) トリアゾール含有マクロライド及びその眼科的使用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100712

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100712

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120918

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121217

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121225

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130318

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130521